Today: 17 May 2026
Mastercard stock tumbles below $500 after-hours as tariffs, AI fears rattle Wall Street
24 February 2026
1 min read

Mastercard stock tumbles below $500 after-hours as tariffs, AI fears rattle Wall Street

New York, Feb 23, 2026, 18:51 EST — After-hours

  • Mastercard lost ground in after-hours action, caught up in the broad selloff that hit U.S. stocks.
  • Visa and American Express slid alongside other payments stocks; PayPal, on the other hand, surged.
  • Fresh U.S. data is on deck, and traders are eyeing the next round of tariff headlines as the session approaches.

Mastercard Incorporated (NYSE:MA) slid 5.7% to $496.03 in after-hours trading Monday, following a steep decline earlier in the session. Shares swung from $490.05 to $525.19 during the day.

Wall Street’s drop followed fresh tariff jitters and concerns over rapid advances in artificial intelligence shaking up business models. The Dow shed 1.66%, with the S&P 500 down 1.04% and the Nasdaq off 1.13%. “Sell first, assess later,” summed up U.S. Bank Wealth Management strategist Tom Hainlin. Reuters

Mastercard’s challenge right now isn’t so much about any shock specific to its own business; it’s more about sentiment. The card networks depend on stable consumer spending as well as cross-border flows, and when traders start seeing signs of slower transactions or fading risk appetite, they’re quick to hit the sell button.

Visa slipped 4.5% to $306.52 late, while American Express dropped 7.2% at $321.24. PayPal, though, jumped 5.8% to $44.05 as takeover chatter swirled around the name.

Mastercard is teaming up with Ericsson to bring together Ericsson’s fintech platform and Mastercard Move, its cross-border payments service, starting with markets in the Middle East and Africa. Mastercard says Move reaches 200 countries and territories. Ericsson, for its part, reports that its platform covers 22 countries and handles over 4 billion transactions monthly. Pratik Khowala, who leads Mastercard’s transfer-solutions division, called the integration a way to “open new pathways” for companies looking to expand payment options. TradingView

Mastercard investors are watching the competitive landscape closely. Usually, the major networks move together, unless a specific catalyst sets one company apart.

The real danger? Tariff swings start weighing on hiring and spending, regardless of how the regulations shift. European Central Bank President Christine Lagarde put it bluntly—companies need “rules of the road” to feel comfortable investing. Over at EY-Parthenon, chief economist Gregory Daco called the pace of change “impossible to plan.” Reuters

Tuesday brings a fresh batch of U.S. consumer-confidence figures and housing data, with comments from Federal Reserve officials also on tap. After the bell, Trump delivers his State of the Union address.

Stock Market Today

  • Today's Top Stock Movers: Coinbase, Cerebras, Figma, Microsoft
    May 17, 2026, 2:42 AM EDT. Cerebras Systems slipped after a strong debut on Thursday, indicating early profit-taking. Meanwhile, Figma surged following an upward revision of its financial outlook, boosting investor confidence. Other notable movers include Coinbase and Microsoft, which showed mixed trading activity amid market volatility. This snapshot reflects shifting investor sentiment amid earnings updates and market conditions.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Plug Power stock dips before the bell as tariff jitters and dilution fears linger
Previous Story

Plug Power stock dips before the bell as tariff jitters and dilution fears linger

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on
Next Story

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on

Go toTop